Company patents
Imperative Care, Inc.
Imperative Care, Inc. demonstrates a strong focus on core medical device areas, with Drug Delivery Devices (74.8% of portfolio) and Medical Diagnostics & Surgery (69.2% of portfolio) dominating its patent strategy. While both categories saw significant year-over-year growth in 2024 (+23.8% and +42.1% respectively), the notable decline in patenting activity across all categories in 2025 and so far in 2026, particularly in Implants & Prosthetics which saw a 100.0% drop in 2026 after a 200.0% surge in 2025, suggests a potential strategic re-evaluation or a shift in R&D priorities.
Patent Trend by Technology Area
Yearly patent publications since 2023
Product themes
Product-level themes inferred from filings since 2023, with category chips showing where each theme appears. Select a theme to filter the patents below.
107 US filings (since 2023) · 4 categories · 5 themes
Minimally invasive medical devices, typically flexible tubes, inserted into body lumens to deliver substances, remove obstructions, or perform localized treatments like ablation, dialysis, or drainage.
Design and application of devices that are inserted into the body or implanted to treat diseases, modulate physiological functions, or repair anatomical structures.
Focuses on the mechanical design, articulation, and actuation of hand-held or robotic surgical instruments, including improvements in stapling, cutting, grasping, and tissue manipulation.
Systems and methods that use imaging technologies, computer vision, and augmented reality to provide real-time guidance, localization, and visualization during surgical procedures or for detailed anatomical assessment.
Implantable devices designed to repair, replace, or assist the function of blood vessels or heart structures, including stents, valves, and annuloplasty rings.
Patents
Showing 11-20 of 131